ASX - By Stock
|
PER |
Re:
Ann: Percheron Therapeutics Limited Corporate Presentation
|
|
Bluesaint
|
148 |
56K |
6 |
16/09/24 |
16/09/24 |
ASX - By Stock
|
148
|
56K
|
6
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
Bluesaint
|
1.6K |
445K |
2 |
11/09/24 |
11/09/24 |
ASX - By Stock
|
1.6K
|
445K
|
2
|
|
ASX - By Stock
|
PER |
Re:
Assumptions
|
|
Bluesaint
|
35 |
10K |
3 |
11/07/24 |
11/07/24 |
ASX - By Stock
|
35
|
10K
|
3
|
|
ASX - By Stock
|
PER |
Re:
Ann: Notification regarding unquoted securities - PER
|
|
Bluesaint
|
87 |
20K |
3 |
06/07/24 |
06/07/24 |
ASX - By Stock
|
87
|
20K
|
3
|
|
ASX - By Stock
|
PER |
Re:
Ann: Notification regarding unquoted securities - PER
|
|
Bluesaint
|
87 |
20K |
3 |
05/07/24 |
05/07/24 |
ASX - By Stock
|
87
|
20K
|
3
|
|
ASX - By Stock
|
PER |
Re:
PER…..management needed..
|
|
Bluesaint
|
12 |
4.6K |
4 |
01/07/24 |
01/07/24 |
ASX - By Stock
|
12
|
4.6K
|
4
|
|
ASX - By Stock
|
PER |
Re:
FDA approves Sareptas Srp901 for the whole population
|
|
Bluesaint
|
63 |
20K |
10 |
27/06/24 |
27/06/24 |
ASX - By Stock
|
63
|
20K
|
10
|
|
ASX - By Stock
|
PER |
Re:
FDA approves Sareptas Srp901 for the whole population
|
|
Bluesaint
|
63 |
20K |
2 |
23/06/24 |
23/06/24 |
ASX - By Stock
|
63
|
20K
|
2
|
|
ASX - By Stock
|
PER |
Re:
FDA approves Sareptas Srp901 for the whole population
|
|
Bluesaint
|
63 |
20K |
8 |
23/06/24 |
23/06/24 |
ASX - By Stock
|
63
|
20K
|
8
|
|
ASX - By Stock
|
SPQ |
Re:
Ann: Steam Engine Resource Expansion and Mining Study plans
|
|
Bluesaint
|
121 |
40K |
3 |
22/06/24 |
22/06/24 |
ASX - By Stock
|
121
|
40K
|
3
|
|
ASX - By Stock
|
PER |
Re:
FDA approves Sareptas Srp901 for the whole population
|
|
Bluesaint
|
63 |
20K |
1 |
21/06/24 |
21/06/24 |
ASX - By Stock
|
63
|
20K
|
1
|
|
ASX - By Stock
|
PER |
Re:
Clean insights and information easily found
|
|
Bluesaint
|
157 |
40K |
4 |
15/06/24 |
15/06/24 |
ASX - By Stock
|
157
|
40K
|
4
|
|
ASX - By Stock
|
PER |
Re:
Clean insights and information easily found
|
|
Bluesaint
|
157 |
40K |
1 |
12/06/24 |
12/06/24 |
ASX - By Stock
|
157
|
40K
|
1
|
|
ASX - By Stock
|
PER |
Re:
Clean insights and information easily found
|
|
Bluesaint
|
157 |
40K |
3 |
12/06/24 |
12/06/24 |
ASX - By Stock
|
157
|
40K
|
3
|
|
ASX - By Stock
|
PER |
Re:
Clean insights and information easily found
|
|
Bluesaint
|
157 |
40K |
6 |
12/06/24 |
12/06/24 |
ASX - By Stock
|
157
|
40K
|
6
|
|
ASX - By Stock
|
PER |
Re:
Clean insights and information easily found
|
|
Bluesaint
|
157 |
40K |
6 |
12/06/24 |
12/06/24 |
ASX - By Stock
|
157
|
40K
|
6
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
Bluesaint
|
1.6K |
445K |
4 |
10/06/24 |
10/06/24 |
ASX - By Stock
|
1.6K
|
445K
|
4
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
Bluesaint
|
1.6K |
445K |
7 |
10/06/24 |
10/06/24 |
ASX - By Stock
|
1.6K
|
445K
|
7
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
Bluesaint
|
1.6K |
445K |
6 |
10/06/24 |
10/06/24 |
ASX - By Stock
|
1.6K
|
445K
|
6
|
|
ASX - By Stock
|
PER |
Re:
Clean insights and information easily found
|
|
Bluesaint
|
157 |
40K |
0 |
10/06/24 |
10/06/24 |
ASX - By Stock
|
157
|
40K
|
0
|
|
ASX - By Stock
|
PER |
Re:
Ann: Percheron appoints Dr Cathryn Clary as Chief Medical Advisor
|
|
Bluesaint
|
129 |
37K |
2 |
09/06/24 |
09/06/24 |
ASX - By Stock
|
129
|
37K
|
2
|
|
ASX - By Stock
|
PER |
Re:
Ann: Percheron appoints Dr Cathryn Clary as Chief Medical Advisor
|
|
Bluesaint
|
129 |
37K |
3 |
09/06/24 |
09/06/24 |
ASX - By Stock
|
129
|
37K
|
3
|
|
ASX - By Stock
|
PER |
Re:
Ann: Percheron appoints Dr Cathryn Clary as Chief Medical Advisor
|
|
Bluesaint
|
129 |
37K |
2 |
08/06/24 |
08/06/24 |
ASX - By Stock
|
129
|
37K
|
2
|
|
ASX - By Stock
|
PER |
Re:
Ann: Percheron appoints Dr Cathryn Clary as Chief Medical Advisor
|
|
Bluesaint
|
129 |
37K |
9 |
08/06/24 |
08/06/24 |
ASX - By Stock
|
129
|
37K
|
9
|
|
ASX - By Stock
|
PER |
Re:
Ann: Phase IIb study of ATL1102 in DMD completes recruitment
|
|
Bluesaint
|
238 |
70K |
5 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
238
|
70K
|
5
|
|
ASX - By Stock
|
PER |
Re:
Ann: Phase IIb study of ATL1102 in DMD completes recruitment
|
|
Bluesaint
|
238 |
70K |
4 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
238
|
70K
|
4
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
Bluesaint
|
1.6K |
445K |
1 |
28/05/24 |
28/05/24 |
ASX - By Stock
|
1.6K
|
445K
|
1
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
Bluesaint
|
1.6K |
445K |
4 |
20/05/24 |
20/05/24 |
ASX - By Stock
|
1.6K
|
445K
|
4
|
|
ASX - By Stock
|
EQR |
Re:
Ann: Investor Update / Webinar
|
|
Bluesaint
|
36 |
10K |
4 |
14/05/24 |
14/05/24 |
ASX - By Stock
|
36
|
10K
|
4
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
Bluesaint
|
1.6K |
445K |
8 |
09/05/24 |
09/05/24 |
ASX - By Stock
|
1.6K
|
445K
|
8
|
|
ASX - By Stock
|
KNM |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Bluesaint
|
4 |
2.4K |
1 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
4
|
2.4K
|
1
|
|
ASX - By Stock
|
PER |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Bluesaint
|
58 |
18K |
13 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
58
|
18K
|
13
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
Bluesaint
|
1.6K |
445K |
0 |
27/04/24 |
27/04/24 |
ASX - By Stock
|
1.6K
|
445K
|
0
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
Bluesaint
|
1.6K |
445K |
2 |
27/04/24 |
27/04/24 |
ASX - By Stock
|
1.6K
|
445K
|
2
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
Bluesaint
|
1.6K |
445K |
0 |
27/04/24 |
27/04/24 |
ASX - By Stock
|
1.6K
|
445K
|
0
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
Bluesaint
|
1.6K |
445K |
1 |
26/04/24 |
26/04/24 |
ASX - By Stock
|
1.6K
|
445K
|
1
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
Bluesaint
|
1.6K |
445K |
4 |
26/04/24 |
26/04/24 |
ASX - By Stock
|
1.6K
|
445K
|
4
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
Bluesaint
|
1.6K |
445K |
4 |
26/04/24 |
26/04/24 |
ASX - By Stock
|
1.6K
|
445K
|
4
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
Bluesaint
|
1.6K |
445K |
5 |
26/04/24 |
26/04/24 |
ASX - By Stock
|
1.6K
|
445K
|
5
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
Bluesaint
|
1.6K |
445K |
15 |
26/04/24 |
26/04/24 |
ASX - By Stock
|
1.6K
|
445K
|
15
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
Bluesaint
|
1.6K |
445K |
2 |
25/04/24 |
25/04/24 |
ASX - By Stock
|
1.6K
|
445K
|
2
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
Bluesaint
|
1.6K |
445K |
5 |
25/04/24 |
25/04/24 |
ASX - By Stock
|
1.6K
|
445K
|
5
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
Bluesaint
|
1.6K |
445K |
8 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
1.6K
|
445K
|
8
|
|
ASX - By Stock
|
EQR |
Re:
Ann: Investor Update NWR Sydney Resources Lunch 2024
|
|
Bluesaint
|
47 |
16K |
0 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
47
|
16K
|
0
|
|
ASX - By Stock
|
PER |
Re:
PER - Megathread
|
|
Bluesaint
|
366 |
123K |
3 |
01/04/24 |
01/04/24 |
ASX - By Stock
|
366
|
123K
|
3
|
|
ASX - By Stock
|
PER |
Re:
PER - Megathread
|
|
Bluesaint
|
366 |
123K |
7 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
366
|
123K
|
7
|
|
ASX - By Stock
|
PER |
Re:
PER - Megathread
|
|
Bluesaint
|
366 |
123K |
2 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
366
|
123K
|
2
|
|
ASX - By Stock
|
PER |
Re:
PER - Megathread
|
|
Bluesaint
|
366 |
123K |
7 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
366
|
123K
|
7
|
|
ASX - By Stock
|
KNM |
Re:
Ann: Suspension from Quotation
|
|
Bluesaint
|
15 |
8.9K |
1 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
15
|
8.9K
|
1
|
|
ASX - By Stock
|
KNM |
Re:
Ann: Suspension from Quotation
|
|
Bluesaint
|
15 |
8.9K |
1 |
24/03/24 |
24/03/24 |
ASX - By Stock
|
15
|
8.9K
|
1
|
|